| # | Drug | Count |
|---|---|---|
| 0 | LEFLUNOMIDE | 1801 |
| 1 | DICLOFENAC SODIUM | 1764 |
| 2 | RITUXIMAB | 1721 |
| 3 | DICLOFENAC | 1715 |
| 4 | METHOTREXATE SODIUM | 1679 |
| 5 | ADALIMUMAB | 1613 |
| 6 | ADALIMUMAB-ADAZ | 1583 |
| 7 | TOCILIZUMAB | 1582 |
| 8 | CETIRIZINE HYDROCHLORIDE | 1573 |
| 9 | ALENDRONATE SODIUM | 1572 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRICLOSAN | 88 | 0.1525 |
| 1 | HYDROCORTISONE BUTYRATE | 289 | 0.1463 |
| 2 | TRIPROLIDINE HYDROCHLORIDE | 23 | 0.1179 |
| 3 | CAFFEINE CITRATE | 275 | 0.1178 |
| 4 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 76 | 0.1155 |
| 5 | DICLOFENAC POTASSIUM | 1013 | 0.0916 |
| 6 | GOLD | 521 | 0.0897 |
| 7 | CORTISONE ACETATE | 1112 | 0.0890 |
| 8 | PSEUDOEPHEDRINE HCL | 903 | 0.0825 |
| 9 | DESOXIMETASONE | 1487 | 0.0771 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 1926 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1893 |
| 2 | Corticosteroid [EPC] | 1819 |
| 3 | Antirheumatic Agent [EPC] | 1801 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 1738 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 1647 |
| 6 | Vitamin C [EPC] | 1604 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 1551 |
| 8 | Vitamin B12 [EPC] | 1538 |
| 9 | Aminosalicylate [EPC] | 1533 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 153 | 0.0826 |
| 1 | Provitamin D2 Compound [EPC] | 870 | 0.0292 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 186 | 0.0213 |
| 3 | Antirheumatic Agent [EPC] | 1801 | 0.0170 |
| 4 | Aminosalicylate [EPC] | 1533 | 0.0152 |
| 5 | beta3-Adrenergic Agonist [EPC] | 657 | 0.0138 |
| 6 | Antiseptic [EPC] | 55 | 0.0126 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 1647 | 0.0119 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 952 | 0.0113 |
| 9 | Interleukin-12 Antagonist [EPC] | 1042 | 0.0100 |